Programme Regulations: 2024/25 Degree of Master of Research (MRes) offered in the Faculty of Medical Sciences: General Programme: MRes Medical & Molecular Biosciences (4807F) Subject Specialist Programmes: MRes Immunobiology (4813F) MRes Ageing and Health (4814F) MRes Cancer (4816F) MRes Regenerative Medicine and Stem Cells (4817F) MRes Neuroscience (4818F) MRes Biotechnology and Business Enterprise (4819F) MRes Toxicology (4820F)* MRes Translational Medicine and Therapeutics (4822F) MRes Animal Behaviour (4825F) MRes Epidemiology (4826F) MRes Medical Genetics (4827F) MRes Molecular Microbiology (4828F) MRes移植(4829F)MRES进化和人类行为(4832F)MRES线粒体生物学和医学(4834F)MRES糖尿病(4835F)MRES MRES神经肌肉疾病(4836F) (4840F)健康和疾病(4862F)MRES分子细胞生物学(4862F)MRES临床运动生理学(仅向内部互生候选者开放)(4863F)MRES生物制作和生物启动(4864f)(4864f)MRES(4864f)MRES药物输送和纳米赛(4869f)iSTERTARTY和DELTARS MISCISES(4869F)conciences(4869f)conciences(4869f)sciences(4869F)来自印度尼西亚大学的牙科学生(4872F)
在某些情况下,英国立法和法定监管机构(如健康安全管理局)将那些对管理活动安全负有特定法律责任的人称为责任人。此术语的使用不应与国防法规中概述的任何责任要求相混淆。在 DSA 中,责任源于《尼姆罗德审查》的结果,指的是加强的注意义务安排和明确定义的角色和职责,这些是法律上负责的个人能够履行其职责以有效减轻和判断风险所必需的。如果国防法规要求责任人,则该要求的详细信息将包含在法规中。
3.4.8 布置 E 的文字 ...................................................................................................................... 3-14 附件 C ...................................................................................................................................... 3-20 表 C1:ERP 和 EAH 的限制 ................................................................................................ 3-20 表 C2:假定平均地形海拔 (AATE) 的值 ............................................................................. 3-20 地图。加拿大/美国共享安排 ................................................................................................ 3-21 图 1。加拿大/美国共享安排 421-430 MHz 频段 ...................................................................................................................... 3-22 图 2。加拿大/美国共享安排 421-430 MHz 频段协调区 ............................................................................................................................. 3-23 图 3。加拿大/美国共享安排 421-430 MHz 频段重叠协调 ............................................................................................................................. 3-24
Pharmacy Practice Act A 17-92-101 Definitions 1-6 17-92-102 Exemptions 7 17-92-103 Pharmacy laws unaffected 7 17-92-104 Privilege tax unaffected 8 17-92-105 Prohibited acts – Penalties 8 17-92-106 Injunctions 8 17-92-107 Prosecutions – Disposition of fines 8 17-92-108 Fees 8-11 17-92-111使徒行传1997年,编号1204 11 17-92-113药剂师的专业责任 - 禁止 - 定义12 17-92-114互惠互惠12 17-92-115根据州协议下的管理和分配要求12-15 15-15 17-92-116对家庭全部肾脏diasney dialysis 17-9-9-9-92-1117-9-92-1117-92-117-92-1117-9-92-117-9-9-117-9-1117 17-92-118 Point-of-care treatment 17 17-92-119 Prescription delivery standards – Definition 17 17-92-120 New prescription requests and new refill requests from prescriber 17-18 17-92-201 Members – Qualifications 18-19 17-92-202 Members – Oath 19 17-92-203 Members – Compensation 19 17-92-204 Organization and proceedings 19 17-92-205 Rules – Enforcement 20-21 17-92-206 Issuance of bulletins – Annual Reports 21 17-92-208 Authorization for payment to the Department of Health 21 17-92-301 License Required 22 17-92-302 Unlicensed practice – Penalty 22 17-92-303 Unlawful use of professional title – Penalty 22 17-92-304 Board administration – Support services 23 17-92-305 Application – Qualification of applicants 23 19-92-306 Examinations 23 17-92-307实习需要23 17-92-308互惠24 17-92-309注册和证书24 17-92-310未能续订24-25 17-92-311 17-92-311撤销,悬架,暂停或非续订 - 理由 - 理由25-26 25-26 17-92-312撤销,并撤销 - 吊销 - 吊销 - 吊销 - 17-92-314撤销 - 上诉27 17-92-315替代处罚27-28 17-92-316专业药房服务所需的凭证28-29 17-92-317犯罪背景检查29-31
研究 12. 开展环境和社会影响评估研究的专家团队 13. 制定环境和社会影响评估研究报告。 14. 公众参与 15. 提交环境和社会影响评估研究报告 16. 审查环境和社会影响研究 17. 邀请公众提出意见 18. 审查公众意见 19. 环境和社会影响评估许可证的决策依据 20. 部委决定 21. 项目批准条件 22. 取消批准